The Efficacy and Safety of Apixaban Versus Warfarin
Are Preserved in Patients With AF and Extreme
Body Weights: Insights From the ARISTOTLE Study

Hohnloser SH, Fudim M, Alexander JH, Wojdyla DM, Ezekowitz JA, Hanna M, Atar D,
Hijazi Z, Bahit MC, Al-Khatib SM, Lopez SJL, Wallentin L, Granger CB, and Lopes RD.
Objective: To determine the safety and effificacy of apixaban relative
to warfarin according to body weight, in patients with AF receiving
pharmacotherapy for the reduction of stroke risk